drugset / Trial / NCT05991401
Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label, fixed-sequence, phase 1 study to evaluate the effect of clarithromycin/rifampicin on the pharmacokinetics of DA-8010 in healthy adults.
Timeline
- Start
- 2023-08-18
- Primary completion
- 2023-11-06
- Completion
- 2023-11-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Rifampin | Small molecule | 600 mg | — |
| Subject | VELUFENACIN | Small molecule | 5 mg | — |
Indications
No indication recorded.